Similar Articles
1151 Management of “very early” hepatocellular carcinoma on cirrhotic patients
1152 Mammalian target of rapamycin inhibition in hepatocellular carcinoma
1153 Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma
1154 Alcohol and hepatocellular carcinoma: A review and a point of view
1155 Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture
1156 Metformin does not improve survival in patients with hepatocellular carcinoma
1157 Current surgical treatment strategies for hepatocellular carcinoma in North America
1158 Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma
1159 Safety of hepatectomy for elderly patients with hepatocellular carcinoma
1160 Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA